These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10841071)

  • 1. [Rationale for using nabumetone and clinical experience].
    Roth SH
    Drugs; 2000; 59 Spec No 1():35-41. PubMed ID: 10841071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Properties and features of nabumetone].
    Davies NM; McLachlan AJ
    Drugs; 2000; 59 Spec No 1():25-33. PubMed ID: 10841070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nabumetone: a clinical appraisal.
    Helfgott SM
    Semin Arthritis Rheum; 1994 Apr; 23(5):341-6. PubMed ID: 8036523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nabumetone. A reappraisal of its pharmacology and therapeutic use in rheumatic diseases.
    Friedel HA; Langtry HD; Buckley MM
    Drugs; 1993 Jan; 45(1):131-56. PubMed ID: 7680981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nabumetone: a "nonacidic" nonsteroidal antiinflammatory drug.
    Dahl SL
    Ann Pharmacother; 1993 Apr; 27(4):456-63. PubMed ID: 8477124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nabumetone: therapeutic use and safety profile in the management of osteoarthritis and rheumatoid arthritis.
    Hedner T; Samulesson O; Währborg P; Wadenvik H; Ung KA; Ekbom A
    Drugs; 2004; 64(20):2315-43; discussion 2344-5. PubMed ID: 15456329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nabumetone. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in rheumatic diseases.
    Friedel HA; Todd PA
    Drugs; 1988 May; 35(5):504-24. PubMed ID: 3293969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy and tolerance of nabumetone in articular and non-articular rheumatic disorders: personal experience during 12 weeks of treatment.
    Coaccioli S; Allegra A; Di Cato L; Puxeddu A
    Panminerva Med; 1998 Jun; 40(2):110-5. PubMed ID: 9689831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nabumetone: a new NSAID for rheumatoid arthritis and osteoarthritis.
    Roth SH
    Orthop Rev; 1992 Feb; 21(2):223-7. PubMed ID: 1538889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of the nonselective NSAID nabumetone : focus on gastrointestinal tolerability.
    Bannwarth B
    Drug Saf; 2008; 31(6):485-503. PubMed ID: 18484783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic and gastrointestinal safety comparisons of etodolac, nabumetone, and oxaprozin from insurance claims data from patients with arthritis.
    Simon LS; Zhao SZ; Arguelles LM; Lefkowith JB; Dedhiya SD; Fort JG; Johnson KE
    Clin Ther; 1998; 20(6):1218-35; discussion 1192-3. PubMed ID: 9916614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gastrointestinal tolerance of nonsteroidal anti-inflammatory agents].
    Bannwarth B
    Drugs; 2000; 59 Spec No 1():17-23. PubMed ID: 10841069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastroscopic evaluation of the effects of nabumetone on the gastrointestinal mucosa of rheumatic patients.
    Bianchi Porro G; Petrillo M; Ardizzone S; Caruso I; Montone F
    Eur J Rheumatol Inflamm; 1991; 11(3):38-42. PubMed ID: 1365479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of selected newer nonsteroidal anti-inflammatory drugs.
    Cummings DM; Amadio P
    Am Fam Physician; 1994 Apr; 49(5):1197-202. PubMed ID: 8154406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of the experience with nabumetone in clinical trials outside of the United States.
    Jenner PN; Johnson ES
    Am J Med; 1987 Oct; 83(4B):110-4. PubMed ID: 3318421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerability of nabumetone: a pilot in vitro study showing absence of injury to articular cartilage.
    Giordano N; Senesi M; Battisti E; Gonnelli S; Franci B; Campagna MS; Mattii G; Palumbo F; Gennari C
    Int J Tissue React; 1996; 18(4-6):105-8. PubMed ID: 9195245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of nabumetone in 4,541 elderly patients from a drug monitoring study.
    Münzel P; Lemmel EE
    Drugs; 1990; 40 Suppl 5():62-4. PubMed ID: 2081496
    [No Abstract]   [Full Text] [Related]  

  • 18. NSAIDs for the new decade--nabumetone?
    Huskisson EC
    Eur J Rheumatol Inflamm; 1991; 11(3):1-2. PubMed ID: 1365475
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety profiles of leading nonsteroidal anti-inflammatory drugs.
    Rothstein R
    Am J Med; 1998 Nov; 105(5A):39S-43S. PubMed ID: 9855175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of nabumetone in patients with rheumatic diseases. Results of an outpatient study involving 8,865 patients.
    Stroehmann I; Giersch KH; Zeidler H; Münzel P
    Drugs; 1990; 40 Suppl 5():50-2. PubMed ID: 2081493
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.